RxElite Announces Preferred Contract Status Awarded for Their Anesthetic Gas Products by Nueterra Healthcare

MERIDIAN, ID, Apr 10 (MARKET WIRE) --
RxElite, Inc. (OTCBB: RXEI) is pleased to announce that it has been
selected by Nueterra Healthcare as a "preferred supplier" to supply Nueterra
Healthcare with anesthetic gas products. Effective February 8, 2008, RxElite
was
awarded the contract listing for all classes of trade for Sojourn(TM)
(Sevoflurane) and Terrell(TM) (Isoflurane). Sevoflurane is the most commonly
used
anesthetic gas in the United States and Isoflurane continues to be used
widely in anesthesia practice.

"We are excited to partner with Nueterra. The agreement has already begun
to
yield significant cost savings to the members of Nueterra," stated Jonathan
Houssian, the CEO of RxElite.

RxElite anesthetic gases are manufactured by MINRAD International, Inc.
(AMEX:
BUF), a leader in the innovation of anesthesia. RxElite holds the exclusive
distribution rights for Minrad-produced anesthetic gases for the human market
in the United States.

About RxElite, Inc.

RxElite, Inc. develops, manufactures, and markets generic prescription
drugproducts in specialty generic markets. These markets include products in the
areas of anesthesia, sterile liquid dose drugs (including respiratory inhalation
drugs, ophthalmics, and injectable drugs), complex active pharmaceutical
ingredients, and other specialty areas. www.RxElite.com

About MINRAD International, Inc.

MINRAD International, Inc. is an interventional pain management company with
real-time image guidance and anesthesia and analgesia product lines, and also
manufactures and markets generic inhalation anesthetics for use in
connection with human and veterinary surgical procedures. The company is
developing a drug/drug delivery system for conscious sedation, which, similar to
nitrous oxide in dental surgery, provides a patient with pain relief without
loss of consciousness. www.minrad.com

About Nueterra Healthcare

Since 1997, Nueterra Healthcare has provided development and management
services for
single and multi-specialty ambulatory surgery centers, specialty hospitals,
physical therapy centers and medical real estate. Nueterra Healthcare currently
owns and manages more than 80 surgical and outpatient facilities in 27 states
across the United States.

Safe Harbor Statement

This press release contains forward-looking statements within the meaning of
the
Private Securities Litigation Reform Act of 1995 involving known and unknown
risks, delays, and uncertainties that may cause our actual results or
performance
to differ materially from those expressed or implied by these
forward-looking statements. These risks, delays, and uncertainties include, but
are not
limited to: risks associated with the uncertainty of future financial
results, our reliance on our sole supplier, the limited diversification of our
product offerings, additional financing requirements, development of new
products,
government approval processes, the impact of competitive products or pricing,
technological changes, the effect of economic conditions and other
uncertainties detailed in the Company's filings with the Securities and
Exchange Commission. The Company undertakes no obligation to update any
forward-looking statements.

For more information:

Corporate Information
Ph: (208) 288-5550
Toll Free: (800) 414-1901
Fax: (208) 288-1191

Investor Relations
Ric Tener
Ph: (208) 288-5550
Fax: (208) 288-1191
Email: Email Contact

Copyright 2008, Market Wire, All rights reserved.

-0-